DK2058328T3 - Derivater af biologisk aktivt peptid VAPEEHPTLLTEAPLNPK - Google Patents
Derivater af biologisk aktivt peptid VAPEEHPTLLTEAPLNPKInfo
- Publication number
- DK2058328T3 DK2058328T3 DK09002378.9T DK09002378T DK2058328T3 DK 2058328 T3 DK2058328 T3 DK 2058328T3 DK 09002378 T DK09002378 T DK 09002378T DK 2058328 T3 DK2058328 T3 DK 2058328T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptide
- vapeehptllteaplnpk
- biologically active
- active peptide
- peptide derivatives
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4716—Muscle proteins, e.g. myosin, actin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56645504P | 2004-04-28 | 2004-04-28 | |
| EP05743126A EP1756152A2 (en) | 2004-04-28 | 2005-04-25 | Biologically active peptide vapeehptllteaplnpk derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2058328T3 true DK2058328T3 (da) | 2011-06-27 |
Family
ID=34967983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09002378.9T DK2058328T3 (da) | 2004-04-28 | 2005-04-25 | Derivater af biologisk aktivt peptid VAPEEHPTLLTEAPLNPK |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7718764B2 (da) |
| EP (2) | EP2058328B1 (da) |
| JP (1) | JP4689664B2 (da) |
| KR (1) | KR101323771B1 (da) |
| CN (1) | CN1976947B (da) |
| AT (1) | ATE505483T1 (da) |
| AU (1) | AU2005238173B2 (da) |
| CA (1) | CA2564179C (da) |
| DE (1) | DE602005027502D1 (da) |
| DK (1) | DK2058328T3 (da) |
| ES (1) | ES2365084T3 (da) |
| NZ (1) | NZ551595A (da) |
| PT (1) | PT2058328E (da) |
| RU (1) | RU2377249C2 (da) |
| TW (1) | TWI353252B (da) |
| WO (1) | WO2005105832A2 (da) |
| ZA (1) | ZA200608865B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3549595A4 (en) * | 2016-12-05 | 2020-07-22 | Otsuka Pharmaceutical Co., Ltd. | COMPOSITION INHIBITING AMYOTROPHY |
| CA3160917A1 (en) * | 2019-12-06 | 2021-06-10 | Cooke Aquaculture Inc. | Peptides for regulating glucose |
| CN112812171B (zh) * | 2021-01-22 | 2022-04-08 | 浙江辉肽生命健康科技有限公司 | 具有氨基酸结构vvrkplnkegkkp的生物活性肽及其制备方法和应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5242821A (en) | 1989-07-10 | 1993-09-07 | Valio, Finnish Co-Operative Dairies' Association | Lactococcus promoter and signal sequences for expression in bacteria |
| IT1231156B (it) | 1989-07-19 | 1991-11-19 | Eniricerche Spa | Espressione e secrezione di interleuchina 1 beta umana matura in bacillus subtilis e mezzi e metodi per il suo ottenimento. |
| DE69433299T2 (de) | 1993-06-15 | 2004-09-09 | E.I. Du Pont De Nemours And Co., Wilmington | Rekombinante spinnerseide analoge |
| JP3286420B2 (ja) | 1993-09-28 | 2002-05-27 | 株式会社ユニシアジェックス | 内燃機関の吸排気弁駆動制御装置 |
| AU2631695A (en) | 1994-06-17 | 1996-01-15 | Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno | Method for introduction of genetic material into microorganisms and transformants obtained therewith |
| US6184208B1 (en) | 1994-06-29 | 2001-02-06 | Immunotech Developments Inc. | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| IL115199A (en) | 1995-09-07 | 2005-05-17 | Opperbas Holding Bv | Composition comprising a polynucleic acid molecule in a liposome and method using said composition |
| ATE273322T1 (de) | 1995-10-24 | 2004-08-15 | Chemo Sero Therapeut Res Inst | Tfpi-verwandte peptide die das wachstums von glatten muskelzellen inhibieren |
| GB9710762D0 (en) * | 1997-05-23 | 1997-07-23 | Cancer Res Inst Royal | Binding complexes |
| EP1015612B1 (en) | 1997-05-27 | 2005-01-26 | Hanil Synthetic Fiber Co., Ltd. | Process for preparing recombinant proteins using highly efficient expression vector from saccharomyces cerevisiae |
| KR19990024297A (ko) | 1997-08-07 | 1999-04-06 | 오종석 | 인체 구강내 치태형성을 억제하는 신규한 유산균 |
| US6100388A (en) | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
| US6562958B1 (en) * | 1998-06-09 | 2003-05-13 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics |
| US6245427B1 (en) | 1998-07-06 | 2001-06-12 | DüZGüNES NEJAT | Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles |
| RU2172322C1 (ru) * | 1999-12-27 | 2001-08-20 | Энтофарм Ко., Лтд. | Аллофероны-иммуномодулирующие пептиды |
| WO2002068601A2 (en) * | 2001-02-28 | 2002-09-06 | Skubitz Keith M | Small peptides capable of modulating the function of cd66 (ceacam) family members |
| KR100889993B1 (ko) | 2001-07-13 | 2009-03-25 | 씨엠에스 펩티드 패턴트 홀딩 컴퍼니 리미티드 | 생물학적 활성 펩타이드 |
| DE10133576A1 (de) * | 2001-07-13 | 2003-01-30 | Martin Klingmueller | Verwendung von physiologisch aktiven Oligopeptiden zur Stabilisierung des Immunsystems |
| CN1223602C (zh) | 2001-07-13 | 2005-10-19 | 一泰医药研究（深圳）有限公司 | 序列号11的生物活性肽 |
| WO2004055045A1 (ja) * | 2002-12-16 | 2004-07-01 | Caf Laboratories Inc. | サルモネラ抗原処方物、それを使用した抗体検査キット及びサブユニットワクチン |
| US20060167229A1 (en) * | 2002-12-18 | 2006-07-27 | Wai Ming Wong | Biologically active peptide conjugates |
-
2005
- 2005-04-19 TW TW094112396A patent/TWI353252B/zh not_active IP Right Cessation
- 2005-04-25 EP EP09002378A patent/EP2058328B1/en not_active Expired - Lifetime
- 2005-04-25 NZ NZ551595A patent/NZ551595A/en not_active IP Right Cessation
- 2005-04-25 EP EP05743126A patent/EP1756152A2/en not_active Withdrawn
- 2005-04-25 ZA ZA200608865A patent/ZA200608865B/xx unknown
- 2005-04-25 DE DE602005027502T patent/DE602005027502D1/de not_active Expired - Lifetime
- 2005-04-25 PT PT09002378T patent/PT2058328E/pt unknown
- 2005-04-25 AU AU2005238173A patent/AU2005238173B2/en not_active Ceased
- 2005-04-25 JP JP2007509950A patent/JP4689664B2/ja not_active Expired - Fee Related
- 2005-04-25 WO PCT/EP2005/004419 patent/WO2005105832A2/en not_active Ceased
- 2005-04-25 DK DK09002378.9T patent/DK2058328T3/da active
- 2005-04-25 ES ES09002378T patent/ES2365084T3/es not_active Expired - Lifetime
- 2005-04-25 CA CA2564179A patent/CA2564179C/en not_active Expired - Fee Related
- 2005-04-25 CN CN2005800129685A patent/CN1976947B/zh not_active Expired - Fee Related
- 2005-04-25 KR KR1020067022224A patent/KR101323771B1/ko not_active Expired - Fee Related
- 2005-04-25 AT AT09002378T patent/ATE505483T1/de not_active IP Right Cessation
- 2005-04-25 RU RU2006137699/13A patent/RU2377249C2/ru not_active IP Right Cessation
-
2006
- 2006-10-27 US US11/553,483 patent/US7718764B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE505483T1 (de) | 2011-04-15 |
| US20080125372A1 (en) | 2008-05-29 |
| ES2365084T3 (es) | 2011-09-21 |
| ZA200608865B (en) | 2009-06-24 |
| NZ551595A (en) | 2010-04-30 |
| TWI353252B (en) | 2011-12-01 |
| AU2005238173A1 (en) | 2005-11-10 |
| RU2006137699A (ru) | 2008-04-27 |
| KR20070004895A (ko) | 2007-01-09 |
| CN1976947A (zh) | 2007-06-06 |
| JP4689664B2 (ja) | 2011-05-25 |
| CA2564179C (en) | 2013-08-06 |
| CN1976947B (zh) | 2010-05-05 |
| TW200538151A (en) | 2005-12-01 |
| CA2564179A1 (en) | 2005-11-10 |
| JP2008501642A (ja) | 2008-01-24 |
| EP2058328A1 (en) | 2009-05-13 |
| KR101323771B1 (ko) | 2013-10-29 |
| AU2005238173B2 (en) | 2010-12-23 |
| DE602005027502D1 (de) | 2011-05-26 |
| US7718764B2 (en) | 2010-05-18 |
| WO2005105832A3 (en) | 2006-06-22 |
| EP2058328B1 (en) | 2011-04-13 |
| PT2058328E (pt) | 2011-07-01 |
| RU2377249C2 (ru) | 2009-12-27 |
| HK1126790A1 (en) | 2009-09-11 |
| WO2005105832A2 (en) | 2005-11-10 |
| EP1756152A2 (en) | 2007-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY169272A (en) | Her2 antibody composition | |
| CY1109722T1 (el) | Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole | |
| RU2010111139A (ru) | Комбинированная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства | |
| EE04911B1 (et) | Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks | |
| BRPI0506864A (pt) | método para conjugar peptìdeos, peptìdeo conjugado, composto e sais, pró-drogas e solvatos farmaceuticamente aceitáveis destes, composição farmacêutica, uso de um composto, e, método para tratamento de doença | |
| ATE509634T1 (de) | Pharmazeutische formulierungen mit incretin- peptid und aprotisch-polarem lösungsmittel | |
| TR200200252T2 (tr) | Şimerik polipeptidler, bunların üretimi için yöntem ve kullanımı | |
| UY28885A1 (es) | 4-fenilamino-quinazolin-6-il-amidas referencia cruzada a solicitud(es) relacionada(s) | |
| EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
| EA200700380A1 (ru) | Конъюгаты глицеринразветвлённого полиэтиленгликоля - гормона роста человека, способ их получения и способы их применения | |
| BRPI0514750A (pt) | derivados amida de 7-amino-3-fenil-diidropirimido[4, 5-d]pirimidinonas, sua fabricação e uso como inibidores de proteìna cinase | |
| AR066199A1 (es) | Metodo para reducir la concentracion del peptido amiloide beta | |
| BRPI0314666B8 (pt) | composição nutricional ou terapêutica utilizável para o tratamento de mamíferos para aumentar a atividade imune | |
| CY1115629T1 (el) | Χρηση ενωσεων πεπτιδιου τρο και φαρμακευτικων συνθεσεων στην θεραπεια της αναιμιας | |
| EA200700976A1 (ru) | Соединения в виде молекул-конъюгатов, обладающих повышенной активностью в отношении включения клеткой | |
| EE200400031A (et) | Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat | |
| DK2058328T3 (da) | Derivater af biologisk aktivt peptid VAPEEHPTLLTEAPLNPK | |
| EA200701852A1 (ru) | Производные аминокислот | |
| PE20050285A1 (es) | Composicion farmaceutica que comprende analogos ciclicos de somatostatina | |
| SV2003000836A (es) | Profarmaco del amino acido estimulantes ref. x-14649 | |
| DE602004017062D1 (de) | Zusammensetzungen aus deramciclan und opioiden zur verwendung als schmerzmittel | |
| EP1730174A4 (en) | PEPTIDE CARRIER FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS | |
| BR0317292A (pt) | Derivados de amida de ácido antranìlico e seu uso farmacêutico | |
| BR0313076A (pt) | Sal de ácido orgânico de amlodipina | |
| DE10390702D2 (de) | 2-Methylthiazolidin-2,4-Dicarbonsäure und deren Salze zur Behandlung von neurodegenerativen Erkrankungen |